Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Quadrivalent Meningococcal Polysaccharide Vaccine
NCT02003313Phase 3Completed
- Sponsor
- Beijing Minhai Biological
- Start
- Nov 2013
- Primary completion
- May 2015
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent meningococcal polysaccharide vaccine in meningococcal meningitis, sponsored by Beijing Minhai Biological. Started Nov 2013; status: completed.
02
Drugs
quadrivalent meningococcal polysaccharide vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT02003313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02003313.